Get the Stockscreener App
100.70
3.13%
-3.25
Pre-market:
102.19
1.49
+1.48%
Billiontoone Inc stock is traded at $100.70, with a volume of 724.16K.
It is down -3.13% in the last 24 hours and up +21.87% over the past month.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
See More
Previous Close:
$103.95
Open:
$104.16
24h Volume:
724.16K
Relative Volume:
1.28
Market Cap:
$4.63B
Revenue:
$354.54M
Net Income/Loss:
$23.65M
P/E Ratio:
217.64
EPS:
0.4627
Net Cash Flow:
-
1W Performance:
-1.65%
1M Performance:
+21.87%
6M Performance:
+9.50%
1Y Performance:
+0.00%
1-Day Range:
$99.14
$105.38
1-Week Range:
$96.76
$105.38
52-Week Range:
$61.96
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
650-460-2551
Address
1035 O'BRIEN DRIVE, MENLO PARK
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
100.70 | 4.78B | 354.54M | 23.65M | 0 | 0.4627 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Dec-01-25 | Initiated | BTIG Research | Buy |
| Dec-01-25 | Initiated | JP Morgan | Overweight |
| Dec-01-25 | Initiated | Jefferies | Hold |
| Dec-01-25 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Initiated | Stifel | Buy |
| Dec-01-25 | Initiated | Wells Fargo | Equal Weight |
| Dec-01-25 | Initiated | William Blair | Outperform |
View All
Billiontoone Inc Stock (BLLN) Latest News
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BillionToOne (BLLN) director awarded 3,017 RSUs of Class A stock - Stock Titan
BillionToOne (BLLN) director and 10% owner awarded 3,017 RSUs in stock grant - Stock Titan
BillionToOne (BLLN) director and 10% owner receives 3,017 RSU equity award - Stock Titan
BillionToOne (BLLN) awards 3,017 RSUs to board director Pagano - Stock Titan
BillionToOne (BLLN) director granted 3,017 RSUs with service-based vesting - Stock Titan
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
BillionToOne (NASDAQ: BLLN) director logs 481,807-share in-kind restructuring across Neotribe funds - Stock Titan
BillionToOne (BLLN) NeoTribe funds move 465,607 shares in restructuring - Stock Titan
BillionToOne(BLLN.US) Officer Sells US$3.79 Million in Common Stock - Moomoo
Nancy Johnson Sells 14,000 Shares of BillionToOne Inc (BLLN) - GuruFocus
BillionToOne CPO Sakakibara sells $785,800 in company stock By Investing.com - Investing.com India
BillionToOne SVP Nancy Johnson sells $1.4m in stock By Investing.com - Investing.com Nigeria
BillionToOne CEO Atay Oguzhan sells $3.79m in stock By Investing.com - Investing.com Australia
BillionToOne CPO Sakakibara sells $785,800 in company stock - Investing.com
BillionToOne SVP Nancy Johnson sells $1.4m in stock - Investing.com
BillionToOne CEO Atay Oguzhan sells $3.79m in stock - Investing.com
BillionToOne (NASDAQ: BLLN) officer sells 14,000 shares under 10b5-1 plan - Stock Titan
BillionToOne (BLLN) CPO sells 8,000 shares under Rule 10b5-1 plan - Stock Titan
3 Stocks Conceivably Trading At Discounts Of Up To 49.6% - simplywall.st
BLLN (NASDAQ) Form 144: Insider resale, 3,418 shares sold reported - Stock Titan
[144] BillionToOne, Inc. SEC Filing - Stock Titan
How Investors May Respond To BillionToOne (BLLN) Conference Spotlight And Apparent Discount To Intrinsic Value - simplywall.st
Earnings call transcript: BillionToOne’s Q1 2026 revenue surges 84% YoY - Investing.com
BillionToOne Q1 2026 slides: 84% revenue surge, 73% gross margin - Investing.com
BillionToOne set to report earnings amid product expansion push By Investing.com - Investing.com Nigeria
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Billiontoone (BLLN) Stock Trends and Sentiment 2026 $BLLN - MarketBeat
Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
BillionToOne Inc. (BLLN) Surges 7.45%: Key Levels and Potential Drivers Behind the RallyVolatility Skew - thelegaladvocate.com
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference - Moomoo
3 Promising Growth Companies With Insider Ownership Up To 27% - Sahm
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect? - Zacks Investment Research
Transcript : BillionToOne, Inc., Q1 2026 Earnings Call, May 06, 2026 - marketscreener.com
BillionToOneStarting 2026 Strong (NASDAQ:BLLN) - Seeking Alpha
Jim Cramer on BillionToOne: “I Say Buy It” - Insider Monkey
BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells - Clinical Lab Products
BillionToOne's (NASDAQ:BLLN) Strong Earnings Are Of Good Quality - 富途牛牛
Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care StockBillionToOne (NASDAQ:BLLN), Desi - Benzinga
Cramer's lightning round: Buy BillionToOne - MSN
Billiontoone Inc Stock (BLLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):